MDM2 and cancer: In our study, we found that ZLM-7 treatment was able to upregulate 14-3-3 sigma expression and inhibit MDM2 expression and subsequently lead to apoptosis and cell-cycle arrest, suggesting the possible extensive use of ZLM-7 for cancer therapy.